Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Arocell Says New Study Shows Clinical Benefit Of UBC Rapid In Detection Of Invasive Bladder Cancer

Aug 22 (Reuters) - AroCell AB (publ)  AROC.ST :
    * NEW STUDY SHOWS CLINICAL BENEFIT OF UBC RAPID IN DETECTION
OF
INVASIVE BLADDER CANCER
    * STUDY INDICATED THAT THE UBC® RAPID TEST EFFECTIVELY
DIFFERENTIATED BETWEEN PATIENTS WITH BLADDER CANCER AND HEALTHY
CONTROLS, BASED ON CYTOKERATIN CONCENTRATIONS

Source text for Eikon:  ID:nMFNbNDCR0 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on IDL Diagnostics AB (publ)

See all news